Keywords: Dementia, KidneyPatients with end-stage kidney disease are vulnerable to cognitive impairment or dementia. Previous studies indicated that end-stage kidney disease subjects manifest prominent white matter hyperintensities. We use fixel-based analysis to examine the tract-specific differences in fixel-based metrics between end-stage kidney disease patients and normal participants. The results demonstrate the pattern of white matter degeneration in end-stage kidney disease patients. Our findings suggest that end-stage kidney disease patients with cognitive impairment exhibit white matter abnormalities. In clinical, the fixel-based analysis may serve as a potential biomarker for monitoring white matter change caused by disease.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords